123 related articles for article (PubMed ID: 14500750)
1. Optimal requirements for high affinity and use-dependent block of skeletal muscle sodium channel by N-benzyl analogs of tocainide-like compounds.
De Luca A; Talon S; De Bellis M; Desaphy JF; Lentini G; Corbo F; Scilimati A; Franchini C; Tortorella V; Camerino DC
Mol Pharmacol; 2003 Oct; 64(4):932-45. PubMed ID: 14500750
[TBL] [Abstract][Full Text] [Related]
2. Increased rigidity of the chiral centre of tocainide favours stereoselectivity and use-dependent block of skeletal muscle Na(+) channels enhancing the antimyotonic activity in vivo.
Talon S; De Luca A; De Bellis M; Desaphy JF; Lentini G; Scilimati A; Corbo F; Franchini C; Tortorella P; Jockusch H; Conte Camerino D
Br J Pharmacol; 2001 Dec; 134(7):1523-31. PubMed ID: 11724759
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of frog skeletal muscle sodium channels by newly synthesized chiral derivatives of mexiletine and tocainide.
De Luca A; Natuzzi F; Falcone G; Duranti A; Lentini G; Franchini C; Tortorella V; Camerino DC
Naunyn Schmiedebergs Arch Pharmacol; 1997 Dec; 356(6):777-87. PubMed ID: 9453464
[TBL] [Abstract][Full Text] [Related]
4. Searching for novel anti-myotonic agents: pharmacophore requirement for use-dependent block of skeletal muscle sodium channels by N-benzylated cyclic derivatives of tocainide.
De Luca A; De Bellis M; Corbo F; Franchini C; Muraglia M; Catalano A; Carocci A; Camerino DC
Neuromuscul Disord; 2012 Jan; 22(1):56-65. PubMed ID: 21802953
[TBL] [Abstract][Full Text] [Related]
5. Constrained analogues of tocainide as potent skeletal muscle sodium channel blockers towards the development of antimyotonic agents.
Catalano A; Carocci A; Corbo F; Franchini C; Muraglia M; Scilimati A; De Bellis M; De Luca A; Camerino DC; Sinicropi MS; Tortorella V
Eur J Med Chem; 2008 Nov; 43(11):2535-40. PubMed ID: 18342401
[TBL] [Abstract][Full Text] [Related]
6. Stereoselective effects of mexiletine enantiomers on sodium currents and excitability characteristics of adult skeletal muscle fibers.
De Luca A; Natuzzi F; Lentini G; Franchini C; Tortorella V; Conte Camerino D
Naunyn Schmiedebergs Arch Pharmacol; 1995 Dec; 352(6):653-61. PubMed ID: 9053738
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of skeletal muscle sodium currents by mexiletine analogues: specific hydrophobic interactions rather than lipophilia per se account for drug therapeutic profile.
De Luca A; Talon S; De Bellis M; Desaphy JF; Franchini C; Lentini G; Catalano A; Corbo F; Tortorella V; Conte-Camerino D
Naunyn Schmiedebergs Arch Pharmacol; 2003 Mar; 367(3):318-27. PubMed ID: 12644906
[TBL] [Abstract][Full Text] [Related]
8. N-aryl-2,6-dimethylbenzamides, a new generation of tocainide analogues as blockers of skeletal muscle voltage-gated sodium channels.
Muraglia M; De Bellis M; Catalano A; Carocci A; Franchini C; Carrieri A; Fortugno C; Bertucci C; Desaphy JF; De Luca A; Conte Camerino D; Corbo F
J Med Chem; 2014 Mar; 57(6):2589-600. PubMed ID: 24568674
[TBL] [Abstract][Full Text] [Related]
9. Increased sodium channel use-dependent inhibition by a new potent analogue of tocainide greatly enhances in vivo antimyotonic activity.
De Bellis M; Carbonara R; Roussel J; Farinato A; Massari A; Pierno S; Muraglia M; Corbo F; Franchini C; Carratù MR; De Luca A; Conte Camerino D; Desaphy JF
Neuropharmacology; 2017 Feb; 113(Pt A):206-216. PubMed ID: 27743929
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of new 2,6-prolylxylidide analogues of tocainide as stereoselective blockers of voltage-gated Na(+) channels with increased potency and improved use-dependent activity.
Franchini C; Corbo F; Lentini G; Bruno G; Scilimati A; Tortorella V; Conte Camerino D; De Luca A
J Med Chem; 2000 Oct; 43(20):3792-8. PubMed ID: 11020295
[TBL] [Abstract][Full Text] [Related]
11. Effects of a new potent analog of tocainide on hNav1.7 sodium channels and in vivo neuropathic pain models.
Ghelardini C; Desaphy JF; Muraglia M; Corbo F; Matucci R; Dipalma A; Bertucci C; Pistolozzi M; Nesi M; Norcini M; Franchini C; Camerino DC
Neuroscience; 2010 Aug; 169(2):863-73. PubMed ID: 20580661
[TBL] [Abstract][Full Text] [Related]
12. 2D- and 3D-QSAR of tocainide and mexiletine analogues acting as Na(v)1.4 channel blockers.
Carrieri A; Muraglia M; Corbo F; Pacifico C
Eur J Med Chem; 2009 Apr; 44(4):1477-85. PubMed ID: 19027197
[TBL] [Abstract][Full Text] [Related]
13. Molecular determinants of mexiletine structure for potent and use-dependent block of skeletal muscle sodium channels.
De Luca A; Natuzzi F; Desaphy JF; Loni G; Lentini G; Franchini C; Tortorella V; Camerino DC
Mol Pharmacol; 2000 Feb; 57(2):268-77. PubMed ID: 10648636
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of inhibition of the Na current by tocainide in guinea-pig isolated ventricular cells.
Tanaka Y; Hisatome I; Sasaki N; Ahmmed GU; Yatsuhashi T; Yamanouchi Y; Uchida K; Hamada T; Taniguchi S; Ogino K; Igawa O; Yoshida A; Shigemasa C; Sato R
Gen Pharmacol; 1999 May; 32(5):541-50. PubMed ID: 10382855
[TBL] [Abstract][Full Text] [Related]
15. High-affinity blockade of voltage-operated skeletal muscle sodium channels by 2,6-dimethyl-4-chlorophenol.
Haeseler G; Gudehus S; Bufler J; Dengler R; Leuwer M
Eur J Anaesthesiol; 2006 Mar; 23(3):190-6. PubMed ID: 16430789
[TBL] [Abstract][Full Text] [Related]
16. High-affinity blockade of voltage-operated skeletal muscle and neuronal sodium channels by halogenated propofol analogues.
Haeseler G; Karst M; Foadi N; Gudehus S; Roeder A; Hecker H; Dengler R; Leuwer M
Br J Pharmacol; 2008 Sep; 155(2):265-75. PubMed ID: 18574460
[TBL] [Abstract][Full Text] [Related]
17. The different use dependences of tocainide and benzocaine are correlated with different effects on sodium channel inactivation.
DeLuca A; Pröbstle T; Brinkmeier H; Rüdel R
Naunyn Schmiedebergs Arch Pharmacol; 1991 Nov; 344(5):596-601. PubMed ID: 1667329
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the pharmacological activity of the major mexiletine metabolites on skeletal muscle sodium currents.
De Bellis M; De Luca A; Rana F; Cavalluzzi MM; Catalano A; Lentini G; Franchini C; Tortorella V; Conte Camerino D
Br J Pharmacol; 2006 Oct; 149(3):300-10. PubMed ID: 16921388
[TBL] [Abstract][Full Text] [Related]
19. Analysis of moricizine block of sodium current in isolated guinea-pig atrial myocytes. Atrioventricular difference of moricizine block.
Ahmmed GU; Hisatome I; Kurata Y; Makita N; Tanaka Y; Tanaka H; Okamura T; Sonoyama K; Furuse Y; Kato M; Yamamoto Y; Ogura K; Shimoyama M; Miake J; Sasaki N; Ogino K; Igawa O; Yoshida A; Shigemasa C
Vascul Pharmacol; 2002 Mar; 38(3):131-41. PubMed ID: 12402511
[TBL] [Abstract][Full Text] [Related]
20. Blockade of voltage-operated neuronal and skeletal muscle sodium channels by S(+)- and R(-)-ketamine.
Haeseler G; Tetzlaff D; Bufler J; Dengler R; Münte S; Hecker H; Leuwer M
Anesth Analg; 2003 Apr; 96(4):1019-1026. PubMed ID: 12651652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
